Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration

CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote ...

AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis

AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced that ...

AI-ECG: A New Market For A Century-Old Test

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...